Home
Conditions
Biliary Tract Neoplasms

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

344 public trials 109 recruiting studies

Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Recruiting

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

NCT07594964

Conditions: Adenocarcinoma, Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer), Biliary Tract Diseases, +21 more
Locations: Peking Union Medical College Hospital Beijing, China

Peking University Cancer Hospital Beijing, China

View Trial Details

Recruiting

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

NCT07466238

Conditions: Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Peking University Cancer Hospital Beijing, China

Peking University Cancer Hospital Beijing, China

View Trial Details

Recruiting

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

NCT06564623

Conditions: Biliary Tract Cancers, Biliary Tract Diseases, Biliary Tract Neoplasms, +8 more
Locations: SKCCC Johns Hopkins Medical Institution Baltimore, Maryland, United States

View Trial Details

Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT06239194

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +74 more
Locations: Sarah Cannon Research Institute Denver, Colorado, United States

Sylvester Comprehensive Cancer Center - University of Miami Health System Miami, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Recruiting

Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer

NCT07569679

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations: Air Force Military Medical University Xi'an, Shaanxi, China

View Trial Details

Recruiting

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

NCT07030140

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +13 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers

NCT07206355

Conditions: Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), +19 more
Locations: University of Nottingham Nottingham, United Kingdom

View Trial Details

Recruiting

HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours

NCT06708663

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +14 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations: Hospital São Carlos Fortaleza, Ceará, Brazil

Hospital São Rafael Salvador, Estado de Bahia, Brazil

Hospital Santa Cruz Curitiba, Paraná, Brazil

IDOR Recife Recife, Pernambuco, Brazil

View Trial Details

Recruiting

Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer

NCT07530445

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +4 more
Locations: Zhiqiang Wang, guangzhou, Other (Non U.S.) 510000 Recruiting Guangzhou, China

View Trial Details

Biliary Tract Neoplasms

Biliary Tract Neoplasms trial results

Related conditions